Halozyme Therapeutics Stock Price on November 14, 2024
| HALO Stock | USD 48.47 0.68 1.42% |
If you're considering investing in Halozyme Stock, it is important to understand the factors that can impact its price. As of today, the current price of Halozyme Therapeutics stands at 48.47, as last reported on the 28th of November, with the highest price reaching 48.74 and the lowest price hitting 47.37 during the day. Halozyme Therapeutics holds Efficiency (Sharpe) Ratio of -0.0946, which attests that the entity had a -0.0946% return per unit of risk over the last 3 months. Halozyme Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Halozyme Therapeutics' Risk Adjusted Performance of (0.06), standard deviation of 3.83, and Market Risk Adjusted Performance of (0.23) to validate the risk estimate we provide.
Halozyme Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Halozyme |
Sharpe Ratio = -0.0946
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HALO |
Estimated Market Risk
| 3.83 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Halozyme Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Halozyme Therapeutics by adding Halozyme Therapeutics to a well-diversified portfolio.
Halozyme Therapeutics Valuation on November 14, 2024
It is possible to determine the worth of Halozyme Therapeutics on a given historical date. On November 14, 2024 Halozyme was worth 58.25 at the beginning of the trading date compared to the closed value of 53.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Halozyme Therapeutics stock. Still, in general, we apply an absolute valuation method to find Halozyme Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Halozyme Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Halozyme Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 59.79 | 60.37 | 58.46 | 58.61 | 830,640 | |
11/14/2024 | 58.25 | 59.80 | 53.84 | 53.96 | 3,219,178 |
| 48.81 | 49.64 | 45.63 | 45.65 | 7,231,186 |
| Backtest Halozyme Therapeutics | | | Halozyme Therapeutics History | | | Halozyme Therapeutics Valuation | Previous | Next |
Halozyme Therapeutics Trading Date Momentum on November 14, 2024
| On November 15 2024 Halozyme Therapeutics was traded for 45.65 at the closing time. The top price for the day was 49.64 and the lowest listed price was 45.63 . The trading volume for the day was 7.2 M. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 15.40% . The trading delta at closing time against the current closing price is 8.25% . |
Halozyme Therapeutics Fundamentals Correlations and Trends
By evaluating Halozyme Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Halozyme Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Halozyme financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Halozyme Therapeutics Stock history
Halozyme Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Halozyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Halozyme Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Halozyme Therapeutics stock prices may prove useful in developing a viable investing in Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California. Halozyme Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 145 people.
Halozyme Therapeutics Stock Technical Analysis
Halozyme Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Halozyme Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Halozyme Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Halozyme Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Halozyme Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Halozyme Therapeutics shares will generate the highest return on investment. By undertsting and applying Halozyme Therapeutics stock market strength indicators, traders can identify Halozyme Therapeutics entry and exit signals to maximize returns
Halozyme Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Halozyme Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Halozyme Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Halozyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.24) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Halozyme Therapeutics. If investors know Halozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Halozyme Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Halozyme Therapeutics is measured differently than its book value, which is the value of Halozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Halozyme Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Halozyme Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Halozyme Therapeutics' market value can be influenced by many factors that don't directly affect Halozyme Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Halozyme Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Halozyme Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Halozyme Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.